Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565

Edge

EIF4EBP1 → SH3GL1

GSE11869_egf1520 - GSE11869 - SiGN-BN HC+Bootstrap	The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol.
GSE15395_egf1520 - GSE15395 - SiGN-BN HC+Bootstrap	HCT116 tumor cells treated with a CDK inhibitor
GSE15396_egf1520 - GSE15396 - SiGN-BN HC+Bootstrap	Peripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor
GSE20685_egf1520 - GSE20685 - SiGN-BN HC+Bootstrap	Microarray-based molecular subtyping of breast cancer
GSE4122_egf1520 - GSE4122 - SiGN-BN HC+Bootstrap	Gene Expression Analysis of Ovarian Samples
GSE4290_egf1520 - GSE4290 - SiGN-BN HC+Bootstrap	Expression data of glioma samples from Henry Ford Hospital
GSE4536_egf1520 - GSE4536 - SiGN-BN HC+Bootstrap	Tumor stem cells more closely mirror the phenotype and genotype of primary human tumors than do cancer cell lines
GSE7696_egf1520 - GSE7696 - SiGN-BN HC+Bootstrap	Glioblastoma from a homogenous cohort of patients treated within clinical trial
GSE8139_egf1520 - GSE8139 - SiGN-BN HC+Bootstrap	Expression data from MCF7/HER2-18 xenografts
GSE8141_egf1520 - GSE8141 - SiGN-BN HC+Bootstrap	Expression data from MCF7 wt and MCF7/HER2-18 xenografts
GSE8894_egf1520 - GSE8894 - SiGN-BN HC+Bootstrap	Prediction of Recurrence-Free Survival in Postoperative NSCLC Patients—a Useful Prospective Clinical Practice